PharmaCorp Closes Acquisitions of Three Pharmacies Across Canada
SASKATOON, Saskatchewan, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has completed the acquisitions of three community pharmacy businesses, two located in Western Canada and one located in Eastern Canada (collectively, the “Acquisitions”).
Western Canada Acquisitions
PharmaCorp has closed its previously announced acquisitions of two PharmaChoice Canada bannered pharmacies located in Western Canada, one of which includes the associated lands and building. The aggregate purchase price for these two acquisitions was $3,400,000, subject to customary adjustments (the “Western Purchase Price”). In accordance with the agreements, 75% of the Western Purchase Price was satisfied with cash on hand and 25% was satisfied by the issuance of common shares of PharmaCorp (the “Common Shares”). The deemed price for the Common Shares was equal to the volume weighted average trading price of the Common Shares on the TSXV during the ten (10) trading day period ending at the close of business on the third business day prior to the closing date.
Eastern Canada Acquisition
PharmaCorp has also closed its previously announced acquisition of a PharmaChoice Canada bannered pharmacy located in Eastern Canada. The purchase price for this acquisition was $5,300,000, subject to customary adjustments (the “Eastern Purchase Price”). The Eastern Purchase Price was satisfied by cash on hand and available funds under the Corporation’s credit facility.
No finder’s fees were paid in connection with the Acquisitions.
“These transactions reflect the continued momentum of our disciplined growth strategy and the strength of our strategic alliance with PharmaChoice Canada,” said Alan Simpson, Executive Chair of PharmaCorp. “With the addition of these three strong community pharmacies in both Western and Eastern Canada, we are expanding our national footprint, preserving independent legacies, and delivering continuity of care for patients. We intend to remain active on the acquisition front in the months ahead.”
About PharmaCorp Rx Inc.
PharmaCorp currently operates seven PharmaChoice Canada bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada branded pharmacies as they come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The Corporation will also acquire independently owned non-PharmaChoice Canada bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner. PharmaCorp shares trade on the TSX Venture Exchange under the symbol: PCRX.
PharmaCorp actively welcomes discussions with pharmacy owners considering succession or sale. For more information about our acquisition program and process, please visit https://www.PharmaCorpRx.ca or contact our team confidentially. We are committed to seamless transitions that protect your legacy and serve your community.
For further information, contact:
Mr. Alan Simpson
Suite #203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Tel: (306) 536-3771
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release contains “forward-looking information” regarding the Corporation within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to: PharmaCorp’s intention to be active on the acquisition front in the months ahead; and the business of PharmaCorp, including the operation and acquisition of pharmacies, including the acquisition of independently owned PharmaChoice Canada branded, and non-PharmaChoice Canada branded, pharmacies. This forward-looking information reflects current beliefs and is based on information currently available to the management of the Corporation and on assumptions the Corporation believes are reasonable. These assumptions include, but are not limited to: the volume of acquisition opportunities presented to PharmaCorp being equal to or greater than historical volumes; and the continued supply of pharmacies for purchase by PharmaCorp at prices satisfactory to PharmaCorp. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive board of directors, third party or regulatory approvals; competition; changes in legislation, including pharmacy regulation, affecting the Corporation; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; and lack of qualified, skilled labour or loss of key individuals. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Corporation’s disclosure documents on the SEDAR+ website at www.sedarplus.ca. Although the Corporation has attempted to identify important risks and factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of the Corporation as of the date of this news release and, accordingly, is subject to change after such date. However, the Corporation expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
© 2025 GlobeNewswire, Inc. All Rights Reserved.
